SES AUA 2022

REVIEW UroToday

Viewing 1-15 of 15 articles

SES AUA 2022: Prolonged Opioid Use Following TURBT: Insurance Claims Review of High-Risk Prescribing to Opioid-Naive Patients

SES AUA 2022: Same Day Discharge in Robotic Assisted Radical Prostatectomy as Part of a Perioperative Pathway at a Single Institution

SES AUA 2022: Gender Disparities in the Clinical Trials and Real-World Utilization of Systemic Therapy in the Management of Urothelial Carcinoma

SES AUA 2022: Racial Variation in MRI-Guided Prostate Biopsy Significant Cancer Detection Among Black and White Men

SES AUA 2022: Family History Of Prostate Cancer Is Not Independently Associated With Differences In Oncologic Outcomes Between African American And Caucasian Men

SES AUA 2022: Examining The Intersections Of Race, Ethnicity, And Insurance Status With Metastatic Prostate Cancer At Presentation

SES AUA 2022: African American Men Have Comparable Risk Of Upgrading On Active Surveillance: A Prospective Observational Prostate Cancer Study

SES AUA 2022: COVID-19’s Drastic Impact On Adhering Patients To An Active Surveillance Protocol For Prostate Cancer

SES AUA 2022: Optimizing Therapy for Locally Advanced Prostate Cancer

SES AUA 2022: Preliminary Results Of A Single Arm Phase II Trial Of Intraoperative Intravesical Mitomycin C During Nephroureterectomy For Urothelial Carcinoma

SES AUA 2022: Extramural Venous Invasion: A Novel Magnetic Resonance Imaging Biomarker For Adverse Pathology In Bladder Cancer

SES AUA 2022: Are Metachronous Bladder Tumors Predictive of Upper Tract Urothelial Carcinoma Recurrence in Patients Treated with Radical or Endoscopic Surgery

SES AUA 2022: Association Between Visibly Complete TURBT and Pathologic Downstaging Following Neoadjuvant Chemotherapy and Radical Cystectomy For Muscle-Invasive Bladder Cancer

SES AUA 2022: Primary Chemoablation of Low-Grade Intermediate-Risk Non-Muscle-Invasive Bladder Cancer Using UGN-102, A Mitomycin-Containing Reverse Thermal Gel (OPTIMA II): A Phase 2B, Open-Label, Single-Arm Trial

SES AUA 2022: Implications of Postponing Cancer Treatment During the Pandemic